Related Experiment Videos
Flufenamic acid in prostaglandin migraine
The International Journal of Neuroscience
|July 1, 1985
Summary
A novel migraine type linked to menstrual cycles shows unique symptoms and responds well to antiprostaglandin drugs, unlike other migraine forms. This suggests a specific subtype, termed prostaglandin migraine, requiring distinct treatment approaches.
Area of Science:
- Neurology
- Gynecology
- Pharmacology
Background:
- Migraine is a common neurological disorder.
- Menstrual cycle disturbances are frequently associated with migraine exacerbations in women.
- Current treatments for migraine lack specificity for certain patient subgroups.
Purpose of the Study:
- To identify and characterize a distinct class of migraine symptomatology.
- To investigate the relationship between menstrual cycle-related migraine and treatment response.
- To propose a new classification for a specific migraine subtype.
Main Methods:
- Clinical observation of patients presenting with migraine.
- Correlation analysis of migraine symptoms with the menstrual cycle.
- Comparative efficacy study of antiprostaglandin drugs versus other migraine treatments.
Main Results:
- A specific migraine presentation associated with menstrual cycle disturbances was identified.
- Patients with this distinct symptomatology demonstrated significantly higher responsiveness to antiprostaglandin medication.
- The efficacy of antiprostaglandin drugs was notably lower in patients with other migraine forms.
Conclusions:
- A new migraine subtype, potentially linked to prostaglandin activity during the menstrual cycle, is proposed.
- This subtype, termed 'prostaglandin migraine,' appears to be uniquely responsive to antiprostaglandin therapy.
- Further research is warranted to elucidate the pathophysiology and optimize treatment for prostaglandin migraine.